Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Motor Activity 54Breast Neoplasms 30Neoplasms 24Lung Neoplasms 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Colonic Neoplasms 6Polycystic Ovary Syndrome 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Obesity 5Fatigue 5Prostatic Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Lymphoma 4Lymphedema 4Esophageal Neoplasms 4Brain Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Peripheral Nervous System Diseases 3Hematologic Neoplasms 3Endometrial Neoplasms 3Skin Neoplasms 2Sarcopenia 2Recurrence 2Rectal Neoplasms 2Neoplasm Metastasis 2Melanoma 2

Interventions

Cyclophosphamide 6Vincristine 3Temozolomide 3Radiotherapy 3Cisplatin 3Automobiles 3fludarabine 2Etoposide 2Eflornithine 2Carboplatin 2omburtamab I-131 1ibrutinib 1gallium Ga 68 dotatate 1etoposide phosphate 1belzutifan 1Zoledronic Acid 1Thiotepa 1Tamoxifen 1Standard of Care 1Radiotherapy, Image-Guided 1Pemetrexed 1ONC206 1Nivolumab 1Mesna 1Maintenance Chemotherapy 1Lomustine 1Isotretinoin 1Induction Chemotherapy 1Hydrocortisone 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive × Exercise × 1 year × Clear all
NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡